>> hi, meg thanks for having me on. so the company, is as a public company, constantly monitoring when it is information that it deemed material to share with the public and that determination was made over the weekend that we should do so on monday morning, so we reported interim results that were reported with our collaborators and what we put out was the extent of the data that we had available and it reported on antibodies across 45 subjects that were tested, all of which produced antibodies, and a subset, four groups in two cohorts, all of whom had developed neutralizing antibodies that's the data we had that's the dad we shared so i want to ask you about, that's the data you had. jack rose said, my guess is that the the numbers are marginal or they would say more. did you have more information and only report what looked good did you have numbers that were marginal, as this person suggests >> meg, look, moderna is a company that is not only trying to develop 15 different drugs and vaccines, but also has engaged in

>> yes, good morning, meg.eciate, every government is very worried for its health and economy we're working in collaboration with many governments around the world. phase one in the u.s we have manufacturing sites that moderna owns and controls in the central states up and running. new hampshire is going to be next in the u.s. we think it's the importance where many nodes of manufacturing around the world where we can provide as many as we can locally in each geography. that's what the government's looking for. >> so you mentioned that lonza will be doing it in the u.s. and switzerla switzerland. are you planning on supplying this in asia >> our goal is to make it available around the world we intend to do as many cycles as makes sense we want to make sure not to do too many locations because of the know how and the race against this virus and so we will work very closely with the governments and lonza's management and manufacturing to get the best use of sites. >> reporter: tell us -- sorry, joe. >> no, go ahe

it involves a lot of consent and disclosure >> meg, we appreciate it long days but meg, we have a three-day weekend ahead well deserved see you on the other side. have a great weekend >>> as all 50 states push in one way or another to restart economies. it is not just restaurants or retailers finding ways to get back to business it is also manufacturers and factory workers moving ahead including jackson center, ohio based airstream that was forced to shut down new trends may force the company to kick production into high gear because demand for their product is expected to surge joining us now, bob wheeler, airstream president. thank you for joining us here on cnbc what is the state of airstream's production in ohio right now >> thanks, brian right now, we are cranking things back up as fast as we can. you mentioned a couple of months shut down, it was about six weeks for us we are seeing stronger than anticipated demand we are hiring now to try to meet that demand. >> they are talking about the summer of staycation but may be the summer going to national parks. >> that whole theory of how

doctor, nice have you and, meg, nice to have you again. meg, i'll turn to you on the moderna question in a moment. doctor, what are you seeing in terms of the covid caseload, the number of icu admissions are the numbers trending in a positive direction >> well, thank you, tyler. it's good to be with you. yes, the numbers are trending in a positive direction. you know, the bay area went to shelter in place early. as a result, we never experienced the massive surge in patients that so tragically affected the new york area and other areas around the world. we continue to diagnosis new cases of covid-19 in the bay area. and continue to provide care through our health care delivery system for those patients. but, it's a much lower number of patients and, by and large, fewer severely ill patients than we're seeing in many parts of the country. but, that doesn't mean that we shouldn't, because we have to remain vigilant and we have to continue to observe the shelter in place and other guidelines that our local authorities have put in place. >> i'

meg joins us with the latest developments meg. >> hi, sara. big news from merck today essentially laying out three different moves solidifying its strategy one was to inlicense an antiviral drug then the other two were two different deals on vaccines one, a a partnership with a non-profit to develop a vaccine based on the same technology used for their ebola vaccine and the other acquiring a company called femis here's many merck lines up in term of the timeline for human trials they're around the june, july time frame they say with the second vaccine that i just mentioned edmentio be in human trials within a few weeks. there are several companies that have started trials and novavax announced it was starting phase one trials in australia. and there's a different collection of companies here, some with proven vaccine experience like merck, johnson & johnson, which is getting in in september and others which are newer companies. merck points out over the last 25 year, there have been only been seven vaccines approved for new disease causing pat

meg and meg. and she gets. bigger tom the whole name bade me big. enough. to. bin laden my. good playing it night america. well you know i didn't you know i'm not. going. to. it was only a ploy to beat you up but now. i am going to do that but i don't think that you need to see before you need. to. put that one that would be by. the mall didn't someone put in a clue it's a. step up until you come to. the course. you need it i'm going to hope that you can. get me. if you. need it need it and so if you all you want me to do you know. me please let me i eat well you know. international memorial awards are now open for entries. professionals are eligible whether you're a freelance journalist media or part of a global news platform to participate published works in video all written for much go to award dot com and enter now. seem wrong. to me. to stamp out disdain adjective and engagement because of the trail. when some many find themselves worlds apart. just to look for common ground. i know team no crowd. no shots. actually felt. when the well it's true i know the 1st one. whi

let's do meg on that end, remdesivir looking at approval in japan morning, meg >> a lot of news coming. moderna part of announcing its quartingly results, saying the fda did give the go ahead yesterday to begin the phase two trial. and also saying that they're finalizing the protocol for the phase three trial, which they now expect to begin in early summer they say based on these timelines, if all goes well, potential regulatory approval in 2021, the ceo on the call this morning talking about that acceleration of timelines. take a listen to what he said. >> today, we're very happy to announce that we received yesterday clearance from the fda to proceed with phase two. in just nine days from rna, the fda gives us a green light we plan to stop the pinnacle trial as soon as safely as possible >> so guys, the next thing we're waiting for is the read-out of the phase one trial. those results should be available, we hope any time now, and that will be the first human trial data on a vaccine for covid-19 and just to remind you about these timelines, they only began that phase one trial in the

meg and meg. in indiana and get to bed or you would. begin with the whole name big me big. time with the. bin laden. i had. it playing here tonight. i didn't let you. go. it was only a ploy you up to now. know my name cleared up i've been kicked out lol nice people you can eat all you need you. know but the one that would you could buy. the mall didn't someone in a lot of occluded say. so publicly you want to do some i moved up or somehow. you need it in the hope that you can. get me. killed all of it need to install if you all you want me to know it got me please get me a pipe i eat all you know. with yeah you like. 54 jets and more than 1300 military personnel are headed to air force base in alaska where is that to say come on i'll show you what's the reason for any type of enhanced u.s. military presence in this area russia. what is it suddenly about the south china sea that makes it so that it 11000000000 barrels of oil. take a look at this map who really owns what kind of says no it belongs to us india says no we claim that that belongs to us both of these countries ha

yes for meg yes for meg >>> plenty of sunshine right now as we look towards the city from treasure island. 61 degrees, that camera is jumping around , it's definitely been breezy, the onshore breezes keeping things breezy. and a degree below 70, we are going to drop down to basically where we dropped off this morning, upper 40s and low 50s, close to what is it normal for high to butchers on wednesday after stretch of cool unsettled weather, it will be within 2-3 degrees of what is normal for may. that means upper 60s around the bay , and the lower 70s and when piglets zoom around and show you what we can expect. it is still going to be cool with that onshore breeze , it's not going to be as strong as it was today. which is why san francisco will warm up. low 70s for the south bay, up to the mid-70s as you head further inland. mid-70s for east bay , and eastern contra costa county reaching up into the upper 70s, not quite 80 degrees yet. and then a warm memorial day weekend, low 70s for most of the north bay, you warmed up significantly to 24 hours ago. will continue that warm up, and neig

meg and meg. when she gets bad or you would. say you were caught in the whole name big me big. time with the. bin laden i had. hidden it playing it night now. do you keep in mind. the money. i have made into any of. them i'm not going. to and it was only going to be you up to now. my name could be that but i didn't click that nice people you meet. me you. know for the one that will be back. in the mall didn't someone put in the clue take. up until you come to the semi in the course of time and. you need to run into the local to that so you can. meet. you all let it meet you and so if you call the morning meeting you know. me will be let me. call you know. financially i don't fly if i'm on a few trips. almost like. a celestial mechanics of the future so crocker was past. 54 drugs and more than 1300 military personnel are headed to heal some air force base in alaska where is that to say come on i'll show you what's the reason for any type of enhanced u.s. military presence in this area rush up. what is it suddenly about the south china sea that makes it so that it is 11. william

meg and meg ringback. in indiana and get to bed or you would. figure tom the whole name big me big. enough. to. get blanket night. i didn't even. go. down to the. it was only a ploy to me you. know my name could be that my friend in the whole needs to be poisoned by me appalled. me in. the hope that one that we could buy. the mall when someone didn't find a clue it's a. sign of having to move on to. the course of how many. families you need to run into the local banks and you can ask. them. block you call me to me and i enjoy your mom. good morning meal i know you know. me will be me i eat all you know to. join me every thursday on the alex simon show and i'll be speaking to us in the world of politics sports business i'm show business i'll see you then. i know team no crowd. no shots no. action don't speak. well strap no thirst to. switch your thirst for action. just when the united states is gradually pulling out of vietnam there is a rush of concern that blow may become another bob so says the administration and says well well the president will let it happen that's what. we are.

meg and meg. to. get to bed or you would. figure tom the whole name big me big. time tom tom knowing. i'm. in my didn't. get night now. am i not. only able i'm. not the one to. only plea you up to now. never my name could be that but i'm in a nice if you really believe. me you. don't like that one that only you could be nice to the mall didn't someone. say. so publicly on to. the course of time and. you need it you know. that you can. feel all that in the. morning needle you know. me will be me i. sense stand a while there are united states there's been the unbelievable winner of the global geographic macroeconomic gambling casino share with the world reserve currency and really smart intelligent financial engineers and software engineers but that. has run up my thought is that this pandemic has exposed incredible wallner abilities in the united states and the united kingdom and that's going to be painful it's going to be a very painful next 10 to 15 years. 54 droughts and more than 1300 military personnel are headed to air force base in alaska where is that to s

meg?> reporter: norah, it was 76 days ago today the national guard moved into new rochelle to n the outbreak. the outbreak. today main street started to slowly reopen, and on wall street, traders were allowed back on the floor for the first time since march. >> good to see you, guys. >> reporter: shortly after new york governor andrew cuomo rang the opening bell -- [bell tolls]. -- stocks surged to their highest levels in nearly three months, fueled by states slowly reopening their economies and developments of potential vaccines. >> we're going to turn the page on covid-19, and we're going to start focusing on reopening and how we reopen and how smart we are in reopening. >> reporter: today traders returned to the floor, but with restrictions, including mandatory masks and temperature checks. asoast, ndsmorial day weekend, unofficial start of summer. in missouri, health officials are now asking these party-goers at the lake of the ozarks to self-quarantine for two weeks. >> thank god we'r

put your probability of success in covid-19 for your antibody approach >> that's a great question, meg. appreciate dr. gottlieb's mentioning of what we do i have to say we're pretty optimistic for two reasons the first reason is what we're trying to do is simply to imitate what nature normally does if you think about a newborn or a baby developing in ute ro, that baby doesn't have a great immune system. what does nature do? the mother sends the antibodies across the placenta so if anything gets to the baby that baby is protected by the antibodies that's a passive transfer of her antibodies to the baby's antibodies after that baby is born, the first mother's milk and subsequent to that, there's antibodies because the baby's immune system is really not up to snuff so this passive transfer of antibodies is a very natural thing. and it goes on all the time as i said in those context and shown, the first nobel prize ever awarded for medicine was for immunology where there was a discovery of if you took people who were already exposed to diphtheria, they had an antibody to be given to other

i agree with annie about that question from meg was really key.ally excellent question from yvette cooper who said to him, you know, you know, you have got to choose between protecting your advisor here and maintaining the tape with ace of the public health crisis that he has undermined vibrating little guidelines and it was very clear that boris johnson was very clear that boris johnson was doubling down, he refused to apologise for the actions of his advisor breaking guidelines that many people around the country observed at great cost to themselves. it really came across as a prime minister who is so reliant oi'i a prime minister who is so reliant on one a prime minister who is so reliant on one advisor that even when that adviser breaks really critical public health advice from the government, he is not prepared or willing to let him go, so he looks incredibly weak and then there were other occasions as well on the commits may. at one point... let's move on to some of the other titles because they are concentrating on the liaison committee as

here's meg oliver. >> miss america!rter: 1971, there she was -- phyllis george, crowned the 50th miss america, something she called the springboard for her life. she joined the cbs family in 1975, the first woman to coanchor the "n.f.l. today." >> the women's superbowl was just held. >> reporter: colleagues said she gave depth to athlete interviews, here with joe namath -- >> what is wrong with the new york jets? >> reporter: -- that male reporters never could. ten years later, george took on morning television on the "cbs morning news." over the years she covered many of the biggest stories in sports and news. >> i hope i broke that glass ceiling for a lot of women. i did for myself. i hope that more women will benefit from what i did. >> reporter: and in still another role, she became first lady of kentucky following her marriage to former governor john y. brown. phyllis george died in lexington, kentucky from a non-covid related illness. she was 70 years old. meg oliver, cbs news. sleep this amazing? ouies contain iq

striking a deal with astrazeneca, and meg tirrell has the details. meg?> hi, melissa, this is the biggest deal that barda, a part of the u.s. company has arc warded for working on covid-19 and warp speed and it's the program trying to accelerate the vaccine by later this year early next year. they awarded to san ofy and half a billion to j&j, and moderna and 1.2 billion to astrazeneca who partnered with oxford. the government gets a guarantee if the vaccine is successful of 300 million doses by october we talked to the ceo pascal o s soriot this morning. >> the vaccine costs very little and we are doing this at no profit during the pandemic it will cost a few dollars and it will be very, very easy to middle and high-income countries and we're working with global organizations and that are supported by the foundation and many other countries to help those countries to the vaccine >>. >> astra zeneca pledging, and they make affordable vaccine, for emergency pandemic use they're not thinking about the profit whereas the pfizer ceo told forbes that financial

meg tirrell joins me with more >> scott gottlieb expects they could be a tool in the toolbox against covid-19 with a resurgence in the fall now, it basically involves the antibodies created by the immune systems when we encounter pathogens and the companies isolating the antibodies of people that recovered from covid-19 and at least three of these companies say they plan to be in human trials this summer regeneron have a strategy of mice to create the drugs and vir with a partner said that this summer we also know that amgen is in the race among others. the news today from ab cellera to have raised from investors. joining us now is the ceo of abcellera to tell us more about their approach dr. carl hanson, thank you for being with us. i wonder if you could just explain what these drugs are, how you develop them and discover them from people who recovered from this disease. >> thanks, meg great to be on the show today. so we have developed a technology that allows us to scan, decode and analyze natural immune systems a human has billion different immune cells each with a different anti

meg? >> steve was mentioning the disconnect between economists and the market there's also disconnect in what we're seeing from where expert says where we need to be on testing and where we are let's take a look at where the u.s. is overall with the number of tests it has been ramping up and you can see over the last week we're sort of getting around 300,000 a day, prominent harvard group suggests we need to be at 900,000 tests per day by tomorrow in order to safely reopen they've done the modeling by state based on the size of each state's outbreaks. you can see a breakdown of which states are doing the most. the gray states in a good position, doing sufficient testing and positive rate of tests is below a 10% threshold, a threshold that w.h.o. recommends in order to see if you're doing enough testing and not missing a lot of cases out there. the darkest states are the ones that are neither meeting the number of tests needed nor that 10% threshold. guys, there's another question here abou

meg tirrell joins us with more hey, meg >> hey, mel. merck announcing three different moves in the covid-19 space and one it's in-licensing an antiviral drug in phase one trials and also making deals on two different vaccine projects using technology that it says has been proven in other vaccines now they plan to start human clinical trials with themore advanced vaccine candidates putting that around june or july after several companies have already started human trials and we did talk to ken frazier, the ceo of merck about the timeliness we should expect and he was more cautious than we've heard of other ceos. here's what he said. >> we'll try approach this in a very responsible and also aggressive fashion so i'm not in a position today to say exactly what the time line will be we will move as quickly and as responsibly as we can. as you know, clinical trials take a long time and if you're going to immunize, a lot of people, millions, if not billions of people we will have to make sure you know exactly what that vaccine will do with pe

stuart got to know meg stuart in dresden. i knew her name from before but we've never met that was the 1st time. i danced congress 2019 makes do it is the 1st choreographer to be made artistic director. she hopes to create lasting connections collective experience through dance improvisation and perhaps even that utopia of a global community. their connections are real the conversations are grounded and they're all sharing different experiences together. and it's great to be in a square with the term attorney and then be in dialogue. with students it's just really i find it really mix and i feel like it has a real promise or no other way to string. ending this whole dance community. so i look at the movements between people i'm interested in social courtesy. they can be so simple when we go to meet someone do we how do you greet them what or how do we navigate social space social interactions and movements. and what causes change what causes people to really mobilize around a certain idea. or to get passion about something wh

meg terrell, it is now up 20% in the after-hours session. guy adami. on in other parts of the drug industry and it speaks to what we have been talking about for a while and big-cap pharma and the biotech stocks yesterday we talked about the ibb making this new high and you go back and meg was just talking about, go back and take a look at what happened to juneau all in the same space. the biotech names regardless of what you think about they're profiting, their prices, their stocks make a lot of sense i think more so now in this environment and that's something we've been saying now for months. >> tim, quick. >> and balance sheets in biotech especially the top of the weightings of the sector are very strong and -- right look at the outperformance anyone attaching the car-t whether it was gilead with the acquisitions and that's the space to be in and certainly where you're getting the multiple allogene up 21%. the one sentence in the major mall merger that could put the whole thing on the rocks we'll tell you what it is. plus why one analyst thinks the

>> ming laven: a good reminder, thanks, meg.l, still ahead on the "cbs weekend news," from outer space to antarctica, lessons on surviving isolation to those who have taken it to the extreme. n to those who have taken it to the extreme. ericans are still stuck at home and struggling. but some people have spent long periods living and actually thriving in isolation. cbs's roxana saberi reports there's a lot to learn. >> three, two, one. >> reporter: when nasa space shuttle "columbia" lifted off in 1998, astronaut jay buckey didn't realize he would learn lessons for living under lockdown today. >> there is a lot of similarities there. you could look at it that your family members, your roommate or whatever there, they are like your crew mates. >> reporter: you may have noticed, confinement with your crew mates can raise tensions at times. how can we keep the peace? >> do what you can do, to keep the communication focused on the issue at hand, not saying things that you know will aggravate the other person just because you want to

. >> breaking news from meg tirrell. meg. >> reporter: hi, andrew. news from moderna i think these are the first human data we're seeing on a covid-19 vaccine program and the positive news. the phase one trial, it observed that after two doses all patients in the trial developed antibodies to the virus. they observed a dose dependent response the higher the dose, the more the vaccine elicited they evaluated eight patients whose data were available showing they developed neutralizing antibodies. across the study they observed antibody levels were similar to or higher than those who recovered from covid-19. they're looking closely at safety and it looked safe and well tolerated in the study and they're pegging july to start the phase 3 trial. becky? >> meg, this is incredibly important. i'm watching the futures you can so he moderna shares up by 20% on this news. the futures themselves are picking up this is the thing that so many people have been waiting for, hearing the potential for a vaccine and seeing in this phase one study that it actually seems

meg? >> hi, john. this is moving at historic speeds moderna says it's got the go ahead to start that mid-stage study of their potential covid-19 vaccine, and at the same time, they are finalizing the protocol for the phase iii trial, which they now expect could begin in early summer 2020 and if all of this goes well, they say they could have potential regulatory approval as early as next year what this phase ii trial is going to do is to enroll up to 600 people in two different age groups half will be ages 18 to 55 and half will be over 55 and participants will be followed for 12 months but we're not going to be waiting those 12 months for the results and for moderna potentially to be moving forward in clinical trials this timeline, you can see going back to january when they first sequenced the vaccine and they had the vaccine sequence finalized, just until now, it's been only a few months these are some of the fastest timelines we've ever seen in history. but there are questions, of course, whether t

meg terrell is here with more. meg? >> when it comes to vaccines, the safety bar is even higher. because, remember, these are medicines being given to healthy people to try to protect them against disease. and of course, in a pandemic, the scale on which the number of people are going to get these things is massive. the main safety issue that experts are talking about is one known as immune enhancement. and right now experts tell us this is really a theoretical issue. it has not been observed in any of the vaccine candidates as of yet. what it means is that the vaccine could potentially make the disease more severe. and this is a phenomenon observed with the dengue virus, that if someone has encountered it once before, the next time they encounter it, it might be worse. it was also seen in rsv vaccine development and it set that field back for 30 years. we talked to dr. stoffels from johnson & johnson about how we can stop it. >> it is a ds enhancing problem, which a vaccine could have when it is not correctly developed. >> so it's obviously very scary and the way to avoid that,

meg has more on this >> it did. the story began on friday when the new head of the government's warp speed effort to get a vaccine to the market made some comments about an early trial he got a peek at. he was on modern's board the implication was that he was talking about modern he left the board around the same time. on early monday morning, we saw the data more saw the numbers and said it was promising. monday afternoon, moderna sold 1.2 million worth of stock tuesday, they said the numbers are too early. niaid, the institute working with moderna and others was pretty silent. i talked with the ceo who pointed to a tweet from vice president pence saying a conk with fauci that was exciting data we asked about one of the claims in the article from a vaccine expert who said maybe they had more data and it just didn't look right >> we take what we do very seriously. we would not have put out only some of the data to make anything look any different than the reality. more importantly, not only is our scientific credibi

here's meg oliver. >> miss america. >> 1971, there she was, phyllis george, crowned the 50th miss america, something she called the springboard for her life. she joined the cbs family in 1975, the first woman to coanchor the nfl today. >> the women-- the super bowl was just held. >> colleagues said she gave depth to athlete interviews here with joe nammality. >> what is wrong with the new york jets that male reports never could. ten years later, george took on morning television on the cbs morning news. over the years she covered many of the biggest stories in sports and news. >> i hope i broke that glass ceiling for a lot of women. i did for myself. i hope that more women will benefit from what i did. >> and still another role she became first lady of kentucky following her marriage to former governor john y brown, phyllis george died in lexington, kentucky, from a noncoindividual related-- covid related illness. she was 70 years old, meg oliver, cbs news. >> straight ahead on the cbs weekend news, a baseball superstar's other field, as a funeral director in the age of covid. also the ne

meg? >> hi, david pfizer and bioentech have started dosing in the u.s. vaccine they're taking four different vaccine candidates into the clinic to find the best candidate to prevent this disease. this is the same technology that moderna is using called messenger rna. they'll be dosing up to 360 healthy subjects in the u.s. trial. the trial in germany began april 23rd they are not the first companies to get into human testing with a human candidate, but they are talking about massive numbers of manufacturing that they're preparing now. pfizer says it could have millions of doses available this year and hundreds of millions of doses available next year if all goes well. they are detailing multiple sites in the u.s. and in europe where they'll be doing that manufacturing. these kinds of timelines here are faster than anything in history. we talked with pfizer's chief scientific officer this morning about how they plan to be sure about the safety and efficacy of this vaccine >> we think that we will have several thousand, 3,000, 4,000 participants and people

meg oliver, cbs news, new york. >> donaldson: and that's the "cbs weekend news."son reporting from wttv, cbs 4 in indianapolis. happy mother's day, and indianght. captioning sponsored by cbs captioned by media access group at wgbh cess.wgbh.org

meg's gathered in protest site one of the capital's hospitals on wednesday since the beginning of the pandemic health workers nationwide have been signing the alarm over what they say has been a chronic lack of safety equipment on funding there's also another legal challenge to any potential negligence in the care sector a prosecutor's opening a case into. in residential homes with more than. we were told from the very beginning the elderly were among the most vulnerable and in the last few weeks we started to get a real sense of just exactly what that meant in from around 40 percent of deaths attributed to 19 have come from one sector. and national scandal is how it's been described by some others have had to know and they're now taking action. families contacted me they decided that the deaths of their relatives raised a number of questions obviously this is due to the fact that a code of silence exists within these institutions they reveal the absence or insufficient application of safety rules as well as the absence of all 8 testing in some cases we're even talking about concealin

meg oliver, cbs news-- >> can you make this virus go away for me?porter: montclair, new jersey. >> o'donnell: we want the virus to go away, too. we'll be right back. go away for me? >> o'donnell: we want the virus to go away, too. we'll be right back. couch, and get your car with touchless delivery to keep you safe. and for even greater peace of mind, all carvana cars come with a seven-day return policy. so, if you need to keep moving, we're here for you. at carvana-- the safer way to buy a car. cdc guidance recommends topical pain relievers first... like salonpas patch large. it's powerful, fda-approved to relieve moderate pain for up to 12 hours, yet non-addictive and gentle on the body. salonpas. it's good medicine. hisamitsu. a lot goes through your mind. with fidelity wealth management, your dedicated adviser can give you straightforward advice and tailored recommendations. that's the clarity you get with fidelity wealth management. (dog vah-mazing!ommendations. this beneful simple goodness is... meaty morsels, a tender texture, with real meat

meg oliver, cbs news, montclair, new jersey. >> o'donnell: president trump says he will stop taking the drug hydroxychloroquine in two days. this as he threatens to whoaldz federal aid from states preparing for mail-in balloting this election season. cbs' weijia jiang joins us from the white house. >> reporter: cbs news has learned through an administration official that some c.d.c. staffers worry their science is being squashed for the sake of reopening, and they entrump, the time tosident trumg is now. >> we're going to open up very big. we're going to open up-- i call it "transition to greatness." >> reporter: but new c.d.c. guidelines for reopening places like restaurants, camps, and schools are far more detailed than the white house believes is necessary. they were shelved for weeks. instead, the administration issued single-page memos with very simple recommendations. on schools, other the memo suggested only having a plan for if students or employees get sick. but latest c.d.c. guidelines go much further, saying if a person in a school building tests positive, schools should cons

meg oliver, cbs news, new york. >> o'donnell: very impressive. we'll be right back.gs... in so many ways. which cage free eggs taste fresher and more delicious? only eggland's best. which organic eggs have more vitamins and less saturated fat? only eggland's best. better taste, better nutrition, better eggs. ...little things... ...can become your big moment. that's why there's otezla. otezla is not a cream. it's a pill that treats plaque psoriasis differently. with otezla, 75% clearer skin is achievable. don't use if you're allergic to otezla. it may cause severe diarrhea, nausea or vomiting. otezla is associated with an increased risk of depression. tell your doctor if you have a history of depression or suicidal thoughts or if these feelings develop. some people taking otezla reported weight loss. your doctor should monitor your weight and may stop treatment. upper respiratory tract infection and headache may occur. tell your doctor about your medicines, and if you're pregnant or planning to be. otezla. show more of you. i want free access for whto research.? yep,

meg oliver, cbs news, new york. >> donaldson: and that's the "cbs weekend news."on reporting from happy mother's day, and indianght. captioning sponsored by cbs captioned by media access group at wgbh access.wgbh.org >>> now at 6:00, new video out of santa cruz county taken just days before a shark attack a few miles away. what we're learning about the fatalencounter and the victim. >> more than surfing, he wanted his life to reflect jesus and the way he treated people. >>> the governor says it could take months before hair salons and barber salons could open up. >>> also an east bay assisted living facility borrows a page from facebook, to wish moms well. >>> we begin with some new drone video out of santa cruz county that shows a possible warning sign not far from the sight of that deadly shark attack yesterday. raymond silver captured this video from his drone. he says he spotted dozens of sharks on that day. that's just about five miles north of yesterday's deadly attack, as shannon longworth reports, the victim was a well known surfer in the community. >> rep

here's cbs' meg oliver. amina mallory has a tough time sharing her mom. it hard when your mom goes to work? >> yes. >> it's almost 10:00 at night. she didn't want to go to bed without seeing me. >> reporter: dr. amina works 12-hourbrooklyn. >> everybody has coronavirus. >> reporter: treating some of its sickeardest part, just breporter: malloy's d died two her alone to raise >> it was devasts a mother, a inspires her even times. >> i em, and i think of all the possibilities that they could help the world with. o see who theyin life. >> reporter: they want to best >> i looked up my mom, and crier-wise and as my mom. >> she saves people's lives. >> reporter: do you think your mom is a super hero? >> yes. i love her so much and her the best mom. >> reporter: she's the best mommy in the world. >> thank you, baby. >> reporter: a super mom saving lives by day and molding three young lives at night. meg oliver, cbs news, new york. >> o'donnell: very impressive. we'll be right back. the best eggs... in so many ways. which cage free eggs taste fresher and more del

let's get to meg tirrell. >> remember back in march the fda basically opened the flood gates for the antibody tests and now they detected some fraudulent tests out there and trying to tighten the guidelines overall so what the new regulations do is say that all companies must submit the validation data to the fda within ten days, also setting thresholds of what the tests need to meet for sensitivity or the ability to detect true positives at 90% and specificity or true negatives at 95% fda also saying as of this point it is authorized 12 tests including just recently from roche and reviewing 200 and that's the scope of how many out there on the market and we want to update you on a story we have been talking today about gilead's remdesivir. the u.s. is going to be controlling distribution of that drug and in a statement to the ylan muoy from fema saying it will be distributed to counties by the commercial provider based on a plan approved by the white house task force so we're learning that they're macking decisions of how it's allocated and analysts saying this is unprecedented in t

meg has more on that and how significant h that data is meg. >> well it's pretty significant as these are the first human clinical trial data results we've seen for a potential covid-19 vaccine but it's very early days that was a phase one trial and included about 45 participants but really just eight of those are the ones that are truly meaningful because those were the ones who had data to show neutralizing antibodies. those are important because they're the ones that block the virus' ability to infect cells, so while they did enroll 45 people between the ages of 18 and 55, they only had data from those eight so far to evaluate that neutral lizing response, however, it was 100% response. they said it looked well tolerated and now they are planning a phase three trial to begin in july and we know they had already plan ned to start a phase two really any day now they only started this phase one trial if you look back at the timeline, in march so this is going incredibly quickly. and guys, as we get the results today by experts in the field, they say yes, they are promising, but they'r

meg? >> jon, thank you so much.stanley erck, the ceo of novavax joins us now stan, thanks for being with us this morning you know, starting with the news today that you've begun your phase one trial of your covid-19 vaccine in australia, tell us why australia? >> well, we've done it there before we have a history of making vaccines for emerging infectious diseases where it's really important, timing is really important to get it started, and then to follow through and we've done this with a pandemic influenza strain and ebola and actually with another two coronaviruses, so this is our third coronavirus vaccine. it just works and so what we do is we start early in australia they have a very good setup for phase one trials and then we go directly into phase two trials in the u.s. and australia following up on that it's a formula that works for us >> and help us understand the time lines a little bit. i think you said you're expecting the preliminary results in july, and then if those are positive i guess moving into t

meg? >> hi, morgan.his is about the dozens of antibody tests on the market for covid-19 right now the fda is revising its policy around how it reviews those tests. in march it kind of opened up the market to the tests saying essentially that manufacturers needed to notify the fda of their own validation of the tests but could enter the market without official use authorization. over concerns about some of how well these tests perform and some of the marketing around the testsp the fda is making stricter those guidelines and essentially they said that they have observed, quote, unscrupulous actors marketing fraudulent test kits they say some claimed they falsely had fda approval or they claimed they could actually diagnose the disease and not just potentially detect the antibodies from the disease or they were authorized for at home testing. the fda says all tests out there need to apply for emergency use authorization within ten days and they're also setting new thresholds for how specific and sensitive,

. >>> let's now get to meg tirrell who joins us with johnson and johnson's head of research meg? >>. [ no audio ] >> if you could give us a status check on where johnson & johnson is in its covid-19 vaccine development timeline and sort of where you see the company standing versus other efforts? we heard from astrazeneca today, they plan to start a phase three trial as soon as next month. are you still planning on phase one in september >> yes, we're still planning to start phase one in september and we closely work with the fda on all regulatory steps towards that it's a careful designed process to go through, we started with 12 different vaccine constructs and selected the best one and we're now testing in animal models and we validated those models, they have been published on monday in science papers showing that animal model is valid and that the vaccine can protect animals and now we are challenging with a vaccine which is a proven vector based delivery where we boost the activity of the dna very much. we can therefore now test it in the month of june. and then we do upscal

. >>> welcome back safety is in focus as companies around the world race to develop new vaccines meg tirrell joins us with a look at where risks in this all can come into play good morning, meg. >> good morning, david vaccines, of course, are a special candidate of medicines because you're giving them to healthy people so the bar for safety has to be extremely high especially when you're talking about a pandemic when hundreds of millions of people or maybe billions will be getting these vaccines the main safety event that experts are on the lookout for is what they tell me right now a theoretical risk, not one they have observed with the vaccines in the early data so far what's known as immune enhancement. the idea a vaccine could make the infection worse. it's something we have seen before with the dengue virus if people have been infected with one strain, if they encounter the next, the antibodies to the previous strain can make the infection worse. we have also seen immune enhancement with vaccines for rsv in the 1960, and it delayed the development of vaccines for 30 years what k